Zepp Health (NYSE:ZEPP) Insider Pengtao Yu Sells 5,749 Shares of Company Stock

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) insider Pengtao Yu sold 5,749 shares of Zepp Health stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $4.30, for a total value of $24,720.70. Following the completion of the transaction, the insider owned 102,742 shares in the company, valued at $441,790.60. The trade was a 5.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Pengtao Yu also recently made the following trade(s):

• On Thursday, September 24th, Pengtao Yu sold 4,251 shares of Zepp Health stock. The shares were sold at an average price of $4.09, for a total value of $17,386.59.

Zepp Health Stock Performance

Shares of NYSE ZEPP opened at $4.13 on Friday. Zepp Health Corporation Sponsored ADR has a 12 month low of $3.85 and a 12 month high of $61.85. The company has a market cap of $60.64 million, a P/E ratio of -1.50 and a beta of 1.87. The business’s 50 day moving average is $4.86 and its two-hundred day moving average is $8.48. The company has a quick ratio of 0.70, a current ratio of 0.90 and a debt-to-equity ratio of 0.30.

Institutional Trading of Zepp Health

A number of large investors have recently bought and sold shares of ZEPP. Monolith Management Ltd acquired a new position in Zepp Health during the fourth quarter worth $3,601,000. Harvest Fund Management Co. Ltd boosted its stake in shares of Zepp Health by 6.7% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,800 shares in the last quarter. Engineers Gate Manager LP boosted its stake in shares of Zepp Health by 44.4% in the 2nd quarter. Engineers Gate Manager LP now owns 20,917 shares of the company’s stock valued at $109,000 after purchasing an additional 6,433 shares in the last quarter. Finally, AXQ Capital LP bought a new stake in shares of Zepp Health in the 2nd quarter worth about $85,000. 52.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Zepp Health in a research report on Tuesday, September 8th. Fundamental Research set a $53.01 price target on Zepp Health and gave the company a “buy” rating in a report on Tuesday, August 11th. Finally, Wall Street Zen downgraded Zepp Health from a “hold” rating to a “sell” rating in a research report on Tuesday, September 8th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $53.01.

About Zepp Health

Zepp Health Corporation (NYSE: ZEPP) is a wearable technology company that develops smart health and fitness devices, along with digital platforms and services designed to help consumers monitor and improve their wellness. Its products collect and analyze information such as activity, sleep, heart rate and other health-related metrics.

The company’s principal consumer brand is Amazfit, which offers smartwatches, fitness trackers and related accessories. Zepp Health also operates the Zepp brand of digital health software and services and has introduced products and services focused on areas such as sleep and hearing health.